Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-term Study of MP-214 in Patients With Chronic Phase or Elderly Schizophrenia

NCT01625897 is registered in ClinicalTrials.gov with Tanabe Pharma Corporation as lead sponsor.

NCT NCT01625897
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01625897 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-term Study of MP-214 in Patients With Chronic Phase or Elderly Schizophrenia
Lead sponsor
Tanabe Pharma Corporation
Phase
Phase 2/3
Overall status
Completed
Start date
May 31, 2012
Completion date
March 31, 2015
Enrollment
125 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia